PharmTech LCGC Sciex Webinar 11.10
|Articles|July 1, 2008

Sequencing Companies Join Genetic Mapping Effort

The 1000 Genomes Project announced that three companies involved in the development of new sequencing instrumentation have joined an international effort to build a detailed map of human genetic variation for medical research.

The 1000 Genomes Project announced that three companies involved in the development of new sequencing instrumentation have joined an international effort to build a detailed map of human genetic variation for medical research. The new participants are 454 Life Sciences, a Roche company (Branford, Connecticut); Applied Biosystems, an Applera Corp. business (Foster City, California); and Illumina Inc. (San Diego, California). The 1000 Genomes Project is an international research consortium formed in January 2008 with a goal of creating a new map of the human genome to show biomedically relevant DNA variations at a higher resolution than current techniques.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.